TechHacker Newsabout 2 hours ago
Chemogenetics enters human trials in China
1 min read
Chemogenetics, which engineers neurons to respond to designer drugs, has entered human clinical trials. Bryan Roth identified seven ongoing trials in China targeting pain, Parkinson's disease, and epilepsy, involving roughly 10 patients. The technique uses DREADDs and low-dose clozapine to precisely modulate brain activity.
Level
Hype check
Tap to vote and see what everyone thinks.
Summary by ByteBrief
